Bioreactors
Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
Published in Vaccine Weekly, November 21st, 2007
The initiation of Phase I was announced on Sept 25, 2006. This project is part of a contract awarded in 2005 by the U.S. Department of Health and Human Services (HHS) aimed at accelerating the development of a new cell culture- based influenza vaccine. Phase II trials involving healthy adult volunteers in the U.S. will focus further on the safety profile and immunogenicity of the cell-based vaccine.
This vaccine was developed using the PER.C6(R) cell line, licensed from Dutch...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-11-21)
More Articles from Vaccine Weekly
- DNA Vaccines
Researchers from University of Duisburg-Essen report recent findings in DNA vaccines - Vaccine Efficacy
Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles - Angiotensins
Research on angiotensins detailed by scientists at Peking Union Medical College - Anthrax Therapy
Studies conducted at Naval Medical Research Center on anthrax therapy recently published - Cytomegalovirus Vaccines
AlphaVax, Inc. publishes research in cytomegalovirus vaccines - DNA Vaccines
Studies from N. Ternette and colleagues provide new data on DNA vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
